PERANEX SB 1.5 Injection – Fighting MDR Pathogens with Synergistic Strength.
PERANEX SB 1.5 Injection – Cefoperazone & Sulbactam Injection combines Cefoperazone, a third-generation cephalosporin antibiotic, with Sulbactam, a β-lactamase inhibitor.
Cefoperazone acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs), leading to cell lysis and death.
Sulbactam blocks β-lactamase enzymes produced by resistant bacteria while also exhibiting mild antibacterial action via PBP binding. This synergistic action enhances the efficacy of Cefoperazone against resistant strains.
Key Benefits of Cefoperazone & Sulbactam Injection – PERANEX SB 1.5 Injection
✅ Broad-Spectrum Coverage – Effective against a wide range of Gram-positive and Gram-negative bacteria, including multidrug-resistant strains.
✅ Superior Action Against MDR Pathogens – Active against resistant organisms such as E. coli, K. pneumoniae, and carbapenem-resistant A. baumannii.
✅ Economical Choice – Delivers high therapeutic value at an affordable cost for healthcare providers and patients.
Recommended By Specialists:
👨⚕️ Infectious Disease Experts: For managing complicated infections caused by resistant organisms.
👨⚕️ General Physicians: Effective for systemic bacterial infections such as septicemia, urinary tract infections, and intra-abdominal infections.
👨⚕️ Critical Care Specialists: Preferred in the management of severe hospital-acquired infections, sepsis, and multidrug-resistant bacterial infections.
INDICATIONS:
✅ Respiratory Tract Infections – Pneumonia, Bronchitis
✅ Urinary Tract Infections – Pyelonephritis, Complicated UTIs
✅ Meningitis – Bacterial meningitis
✅ Sexually Transmitted Infections – Neisseria gonorrhoeae (Gonorrhea)